James Cassidy
Chief Tech/Sci/R&D Officer at SPRINGWORKS THERAPEUTICS, INC.
Net worth: 1 M $ as of 31/03/2024
Profile
James Cassidy is currently the Chief Medical Officer at Springworks Therapeutics, Inc. He previously held positions as the Global Head-Translational Research for Oncology at Hoffmann-La Roche, Inc., Professor-Oncology at the University of Glasgow from 2002 to 2011, Vice President-Translational Development at Celgene LLC from 2016 to 2020, Vice President-Oncology at Bristol Myers Squibb Co. from 2013 to 2016, and VP-Oncology Strategic Program Direction at Regeneron Pharmaceuticals, Inc. from 2020 to 2021.
He obtained his doctorate degree from the University of Glasgow in 1981.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
25/03/2024 | 23,749 ( 0.03% ) | 1 M $ | 31/03/2024 |
James Cassidy active positions
Companies | Position | Start |
---|---|---|
SPRINGWORKS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/08/2021 |
Former positions of James Cassidy
Companies | Position | End |
---|---|---|
REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2021 |
Celgene LLC | Corporate Officer/Principal | 01/01/2020 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/10/2016 |
University of Glasgow | Corporate Officer/Principal | 01/01/2011 |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
Training of James Cassidy
University of Glasgow | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
REGENERON PHARMACEUTICALS, INC. | Health Technology |
SPRINGWORKS THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Celgene LLC |
- Stock Market
- Insiders
- James Cassidy